オンコリスバイオファーマ(株)の貸借新規成約高詳細

主市場業種証券コード/EDINET英名称
東証GRT医薬品4588/ - -
公表日公表担保新規貸付前週比新規借入(自己)前週比新規借入(転貸)前週比
2025/01/10日証協無担保0株0%0株0%49,200株-57.52%
2025/01/10日証協有担保1,450,434株+9999.99%363,590株+2784.72%203,812株+1019.78%
2024/12/30日証協無担保0株0%0株0%115,810株-74.63%
2024/12/30日証協有担保4,100株-99.85%12,604株-96.8%18,201株-95.3%
2024/12/27日証協無担保0株0%0株0%456,401株+486.61%
2024/12/27日証協有担保2,659,020株+252.63%394,292株+26.68%387,006株-4.63%
2024/12/20日証協無担保0株0%0株0%77,803株-30.41%
2024/12/20日証協有担保754,064株-69.52%311,255株+219.1%405,785株+29.07%
2024/12/13日証協無担保0株0%0株0%111,800株+97.12%
2024/12/13日証協有担保2,473,780株-20.16%97,540株-69.11%314,400株-70.17%
2024/12/06日証協無担保0株0%0株0%56,716株-12.61%
2024/12/06日証協有担保3,098,581株+10.04%315,721株-32.18%1,054,113株+39.68%
2024/11/29日証協無担保0株0%0株0%64,900株-47.84%
2024/11/29日証協有担保2,815,794株+218.98%465,500株+328.45%754,637株+58.34%
2024/11/22日証協無担保0株0%0株0%124,430株+19.6%
2024/11/22日証協有担保882,744株-30.39%108,648株+8%476,600株+8.56%
2024/11/15日証協無担保0株0%0株0%104,042株+263.78%
2024/11/15日証協有担保1,268,164株+195.84%100,597株+47.72%439,004株+380.3%
2024/11/08日証協無担保0株0%0株0%28,600株-42.22%
2024/11/08日証協有担保428,664株-45.14%68,099株-39.95%91,402株-29.42%
2024/11/01日証協無担保0株0%0株0%49,500株-10.16%
2024/11/01日証協有担保781,406株-47.24%113,398株-8.33%129,502株-42.85%
2024/10/25日証協無担保0株0%0株0%55,100株+30.57%
2024/10/25日証協有担保1,481,097株+34.76%123,699株+42.67%226,601株-10.19%
2024/10/18日証協無担保0株0%0株0%42,200株-63.53%
2024/10/18日証協有担保1,099,023株-43.46%86,700株-49.8%252,300株-61.26%
2024/10/11日証協無担保0株0%0株0%115,701株+1185.57%
2024/10/11日証協有担保1,943,626株+82.95%172,699株+886.85%651,201株+163.01%
2024/10/04日証協無担保0株0%0株0%9,000株+2.27%
2024/10/04日証協有担保1,062,352株+63.02%17,500株+1.36%247,600株+20.96%
2024/09/27日証協無担保0株0%0株0%8,800株-70.67%
2024/09/27日証協有担保651,668株+92.39%17,265株+1626.5%204,700株+132.88%
2024/09/20日証協無担保0株0%0株0%30,000株+17.65%
2024/09/20日証協有担保338,728株-41.81%1,000株-98.2%87,900株-24.94%
2024/09/13日証協無担保0株0%0株-100%25,500株+17.51%
2024/09/13日証協有担保582,067株+71.58%55,500株+150%117,100株+125.19%
2024/09/06日証協無担保0株0%100株0%21,700株+133.33%
2024/09/06日証協有担保339,239株-14.75%22,200株-74.49%52,000株-15.99%

※株式分割は考慮していませんのでご注意ください。

Page Top